Andrew Bartko
Executive Director Center for Microbiome Innovation
Seminars
Wednesday 11th November 2026
Transitioning from Observational Data to Causal Evidence to Strengthen Clinical & Regulatory Credibility
9:45 am
- Implementing longitudinal and interventional study designs to move beyond correlation and establish causative links required for clinical validation
- Prioritising investment into complex, large-scale trials to demonstrate sustained therapeutic impact across chronic indications and long-term outcomes
- Integrating multi-disciplinary capabilities and datasets to build rigorous, evidence-driven development strategies that support regulatory approval
